A Diagnostic Blind Spot: Deep intronic SVA_E Insertion identified as the most Common Pathogenic Variant Associated with Canavan Disease
Dominguez Gonzalez, C. A.; Bell, K.; Rajagopalan, R.; de Silva, M. G.; Lemes, A.; Zabala, C.; Perez, F.; Cerisola, A.; Vossough, A.; Whitehead, M.; Cunningham, C.; Brown, N.; Quin, R.; Simons, C.; Uebergang, E.; Rius, R.; Kumaheri, M.; Kotes, E.; Vohra, A.; Sullivan, K. E.; Galey, M.; Anderson, Z.; Storz, S.; Ward, S.; Goffena, J.; Gustafson, J. A.; Conway, T.; White, S. M.; Vanderver, A.; Miller, D.
Show abstract
Canavan disease (CD) is a neurodegenerative disorder caused by biallelic disease-causing variants in the ASPA gene. Here, we utilized long-read sequencing (LRS) to investigate eight individuals clinically diagnosed with Canavan disease but without definitive genetic diagnoses. Our analyses identified a recurring previously unreported intronic SVA_E retrotransposon insertion within ASPA in all eight individuals. Surprisingly, the frequency of this variant in population databases suggests it is the most common pathogenic variant in ASPA and should be evaluated in diagnostic testing and carrier screening for CD. Additionally, this finding has implications for the broader rare disease community, as it highlights a substantial blind spot in standard short-read diagnostic pipelines, which historically have missed or overlooked these types of insertions. This discovery highlights the power of emerging technologies, such as LRS and RNA-sequencing (RNA-seq), to bring new classes of variants into diagnostic utility for genetic disorders like CD.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.